Showing results (281-290 of 2,153) with videos related to
Sort By:
Pageof 216
Pharmacology & Toxicology|April 12, 2003
Cholecystokinin activates a variety of intracellular signal transduction mechanisms in rodent pancreatic acinar cellsJohn A Williams, M Dolors Sans, Mitsuo Tashiro, et al.Pharmacology & Toxicology|April 12, 2003
Gastric phenotypic abnormality in cholecystokinin 2 receptor null miceDuan Chen, Chun-Mei Zhao, Rolf Håkanson, et al.Pharmacology & Toxicology|April 12, 2003
Some aspects on the anatomy and function of central cholecystokinin systemsTomas Hökfelt, David Blacker, Christian Broberger, et al.Pharmacology & Toxicology|April 12, 2003
Oestrogen modulates cholecystokinin: opioid interactions in the nervous systemPaul Micevych, Victor Chaban, Arnulfo Quesada, et al.Pharmacology & Toxicology|April 12, 2003
Moleular models for cholecystokinin-A receptorEric S Dawson, Randel M Henne, Laurence J Miller, et al.Pharmacology & Toxicology|April 12, 2003
Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonistsDaniel Fourmy, Chantal Escrieut, Elodie Archer, et al.Pharmacology & Toxicology|April 12, 2003
Human pancreatic acinar cells do not respond to cholecystokininBaoan Ji, Yan Bi, Diane Simeone, et al.Pharmacology & Toxicology|October 31, 2002
Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1Birger Brodin, Carsten Uhd Nielsen, Bente Steffansen, et al.Pharmacology & Toxicology|October 31, 2002
Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in ratsFredrik C Kugelberg, Gustav Apelqvist, Finn BengtssonPharmacology & Toxicology|November 8, 2002
The role of myocardial KATP-channel blockade in the protective effects of glibenclamide against ischaemia in the rat heartRoger J Legtenberg, Gerard A Rongen, Ralph J E Houston, et al.Pageof 216